Loading…
Based on limited metadata, the FDA issued a Warning Letter to Swamp Vapor Lafayette on May 30, 2018, regarding products categorized as "Other" rather than a specific regulated category like drugs or devices. Without access to the full letter text or a detailed subject line, the specific nature of the violations cannot be determined from the available information. The issuing office is not identified in the metadata, which limits clarity on the regulatory pathway or specific FDA division involved. To understand the full scope of enforcement actions and required corrective measures, the complete Warning Letter would need to be reviewed.